BCMA chimeric antigen receptors and uses thereof Grant US-11952428-B2 United States of America 09 Apr 2024
BCMA chimeric antigen receptors and uses thereof Grant US-11939389-B2 United States of America 26 Mar 2024
Anti-ROR1 antibody and ROR1-targeting engineered cells Grant US-11932703-B2 United States of America 19 Mar 2024
Compositions and methods for CAR T cell therapy Grant US-11850262-B2 United States of America 26 Dec 2023
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11851491-B2 United States of America 26 Dec 2023
ANTI-ROR1 ANTIBODY AND ROR1-TARGETING ENGINEERED CELLS Application WO-2023230447-A1 World Intellectual Property Organisation (WIPO) 30 Nov 2023
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11827889-B2 United States of America 28 Nov 2023
Method for generating T-cells compatible for allogenic transplantation Grant US-11820996-B2 United States of America 21 Nov 2023
Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof Grant US-11814432-B2 United States of America 14 Nov 2023
Tolerogenic synthetic nanocarriers for allergy therapy Grant US-11779641-B2 United States of America 10 Oct 2023
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11773396-B2 United States of America 03 Oct 2023
Compositions and methods for CAR T cell therapy Grant US-11759480-B2 United States of America 19 Sep 2023
Antibodies targeting B-cell maturation antigen and methods of use Grant US-11725059-B2 United States of America 15 Aug 2023
Method of reducing mesothelin-expressing tumor burden by administration of T cells… Grant US-11702472-B2 United States of America 18 Jul 2023
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents Grant US-11649288-B2 United States of America 16 May 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses Grant US-11633422-B2 United States of America 25 Apr 2023
Methods and compositions for dosing in adoptive cell therapy Grant US-11633426-B2 United States of America 25 Apr 2023
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-4166148-A1 European Patent Office 19 Apr 2023
BCMA chimeric antigen receptors and uses thereof Grant US-11608382-B2 United States of America 21 Mar 2023
Bispecific CAR T-cells for solid tumor targeting Grant US-11458167-B2 United States of America 04 Oct 2022
Methods and compositions related to combined treatment with antiinflammatories and… Grant US-11426451-B2 United States of America 30 Aug 2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for… Grant US-11413340-B2 United States of America 16 Aug 2022
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11377660-B2 United States of America 05 Jul 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11377638-B2 United States of America 05 Jul 2022
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-11359204-B2 United States of America 14 Jun 2022
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-11298342-B2 United States of America 12 Apr 2022
Methods and compositions for treating cancer Grant US-11248033-B2 United States of America 15 Feb 2022
Immune cell compositions and methods of use Grant US-11242375-B2 United States of America 08 Feb 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11242376-B2 United States of America 08 Feb 2022
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-11235057-B2 United States of America 01 Feb 2022
METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY Application EP-3932950-A1 European Patent Office 05 Jan 2022
ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains Grant US-11149073-B2 United States of America 19 Oct 2021
BCMA-CAR-natural killer (NK) cells and methods related thereto Grant US-11142583-B2 United States of America 12 Oct 2021
Bispecific CAR T-cells for solid tumor targeting Grant US-11123369-B2 United States of America 21 Sep 2021
AFFINITY MATURED AND HUMANIZED BINDING DOMAINS TARGETING ROR2 Application WO-2021180929-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2021
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen… Grant US-11091532-B2 United States of America 17 Aug 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11085021-B2 United States of America 10 Aug 2021
Methods and compositions for dosing in adoptive cell therapy Grant AU-2015336029-B2 Australia 22 Jul 2021
Chimeric antigen receptors targeting b-cell maturation antigen Grant US-11066674-B2 United States of America 20 Jul 2021
Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-co… Grant US-11058722-B2 United States of America 13 Jul 2021
Chimeric antigen receptor (CAR) comprising a CD19-binding domain Grant US-11034750-B2 United States of America 15 Jun 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11028142-B2 United States of America 08 Jun 2021
Humanized BCMA antibody and BCMA-CAR-T cells Grant US-11021542-B1 United States of America 01 Jun 2021
Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses… Grant US-11000549-B2 United States of America 11 May 2021
Chimeric antigen receptor (CAR) comprising a CD22-binding domain Grant US-10981970-B2 United States of America 20 Apr 2021
Antibodies targeting b-cell maturation antigen and methods of use Grant US-10947314-B2 United States of America 16 Mar 2021
Humanized BCMA antibody and BCMA-CAR-T cells Grant US-10927182-B2 United States of America 23 Feb 2021
Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof Grant US-10918665-B2 United States of America 16 Feb 2021
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10900042-B2 United States of America 26 Jan 2021
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10876123-B2 United States of America 29 Dec 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10844387-B2 United States of America 24 Nov 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10837019-B2 United States of America 17 Nov 2020
Chimeric antigen receptors targeting b-cell maturation antigen Grant US-10829769-B2 United States of America 10 Nov 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10829768-B2 United States of America 10 Nov 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10829767-B2 United States of America 10 Nov 2020
Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation… Grant US-10821135-B2 United States of America 03 Nov 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10815487-B2 United States of America 27 Oct 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10815488-B2 United States of America 27 Oct 2020
Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin Grant US-10793641-B2 United States of America 06 Oct 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10767184-B2 United States of America 08 Sep 2020
CELL PENETRATING TRANSPOSASE Application WO-2020169673-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10738312-B2 United States of America 11 Aug 2020
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-10738313-B2 United States of America 11 Aug 2020
Antigen-binding proteins targeting CD56 and uses thereof Grant US-10730941-B2 United States of America 04 Aug 2020
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-3685842-A1 European Patent Office 29 Jul 2020
HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS Application WO-2020150339-A1 World Intellectual Property Organisation (WIPO) 23 Jul 2020
Human mesothelin chimeric antigen receptors and uses thereof Grant US-10640569-B2 United States of America 05 May 2020
Mesothelin-targeted chimeric antigen receptors and uses thereof Grant US-10633441-B2 United States of America 28 Apr 2020
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Grant US-10577417-B2 United States of America 03 Mar 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor Grant US-10568947-B2 United States of America 25 Feb 2020
Antibodies targeting B-cell maturation antigen and methods of use Grant US-10562972-B2 United States of America 18 Feb 2020
Mesothelin-targeted chimeric antigen receptors and methods of making them Grant US-10538588-B2 United States of America 21 Jan 2020
Methods and compositions for dosing in adoptive cell therapy Grant US-10507219-B2 United States of America 17 Dec 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10442849-B2 United States of America 15 Oct 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358474-B2 United States of America 23 Jul 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358473-B2 United States of America 23 Jul 2019
Methods and compositions for treating cancer Grant US-10259855-B2 United States of America 16 Apr 2019
CHIMERIC ANTIGEN RECEPTORS Application WO-2019069125-A1 World Intellectual Property Organisation (WIPO) 11 Apr 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10208285-B2 United States of America 19 Feb 2019
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Grant US-10174095-B2 United States of America 08 Jan 2019
ROR1-SPECIFIC CHIMERIC ANTIGEN RECEPTORS (CAR) WITH HUMANIZED TARGETING DOMAINS Application WO-2018197675-A1 World Intellectual Property Organisation (WIPO) 01 Nov 2018
CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL SWITCHES WITH HUMANIZED TARGETING MOIETIES AND/OR… Application WO-2018075807-A1 World Intellectual Property Organisation (WIPO) 26 Apr 2018
RECOMBINANT IMMUNOTOXINS FOR USE IN THE TREATMENT OF CANCER Application WO-2018064215-A1 World Intellectual Property Organisation (WIPO) 05 Apr 2018
Chimeric antigen receptors targeting B-cell maturation antigen Grant US-9765342-B2 United States of America 19 Sep 2017
METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY Application WO-2016064929-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2016
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application WO-2015188141-A2 World Intellectual Property Organisation (WIPO) 10 Dec 2015
CHIMERIC ANTIGEN RECEPTORS (CAR) FOR USE IN THERAPY AND METHODS FOR MAKING THE SAME Application WO-2015164594-A1 World Intellectual Property Organisation (WIPO) 29 Oct 2015